Cargando…

Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation

Serogroup B is the only major disease-associated capsular group of Neisseria meningitidis for which no protein-polysaccharide conjugate vaccine is available. This has led to the development of multi-component protein-based vaccines that target serogroup B invasive meningococcal disease (IMD), includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brehony, Carina, Rodrigues, Charlene M.C., Borrow, Ray, Smith, Andrew, Cunney, Robert, Moxon, E. Richard, Maiden, Martin C.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012890/ https://www.ncbi.nlm.nih.gov/pubmed/27521232 http://dx.doi.org/10.1016/j.vaccine.2016.08.015

Ejemplares similares

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA
por: Maritan, Martina, et al.
Publicado: (2017)

Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016
por: Rodrigues, Charlene M.C., et al.
Publicado: (2018)

Resolution of a Protracted Serogroup B Meningococcal Outbreak with Whole-Genome Sequencing Shows Interspecies Genetic Transfer
por: Mulhall, Robert M., et al.
Publicado: (2016)

Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
por: Tirani, Marcello, et al.
Publicado: (2015)

Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study
por: Hill, Dorothea M C, et al.
Publicado: (2015)

Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain
por: Pérez-Trallero, Emilio, et al.
Publicado: (2014)

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
por: Gasparini, Roberto, et al.
Publicado: (2016)

Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development
por: Brehony, Carina, et al.
Publicado: (2014)

Meningococcal carriage and disease—Population biology and evolution
por: Caugant, Dominique A., et al.
Publicado: (2009)

W135 Meningococcal Disease in Africa
por: Pollard, Andrew J., et al.
Publicado: (2003)

Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens
por: Rodrigues, Charlene M. C., et al.
Publicado: (2019)

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Correction to: Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
por: Biolchi, Alessia, et al.
Publicado: (2019)

The Influence of IS1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease
por: Kugelberg, Elisabeth, et al.
Publicado: (2010)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
por: Hong, Eva, et al.
Publicado: (2016)

Invasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation
por: Chen, Mingliang, et al.
Publicado: (2018)

Temporal Changes in BEXSERO(®) Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia
por: Mowlaboccus, Shakeel, et al.
Publicado: (2016)

Herd Protection against Meningococcal Disease through Vaccination
por: Clark, Stephen A., et al.
Publicado: (2020)

Bast and other plant fibres
Publicado: (2005)

BAST newsletter—June 2020
por: Di Girolamo, Paolo, et al.
Publicado: (2020)

Author Correction: Invasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation
por: Chen, Mingliang, et al.
Publicado: (2018)

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence
por: Bratcher, Holly B., et al.
Publicado: (2019)

Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a Rapid and Accessible Tool That Exploits Genomic Data in Public Health and Clinical Microbiology Applications
por: Rodrigues, Charlene M. C., et al.
Publicado: (2020)

The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein
por: Mubaiwa, Tsitsi D., et al.
Publicado: (2018)

Variation of the factor H-binding protein of Neisseria meningitidis
por: Brehony, Carina, et al.
Publicado: (2009)

Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year
por: Bratcher, Holly B, et al.
Publicado: (2018)

Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England
por: Christensen, Hannah, et al.
Publicado: (2017)

Genome-Wide Association Studies Identify an Association of Transferrin Binding Protein B Variation and Invasive Serogroup Y Meningococcal Disease in Older Adults
por: Maynard-Smith, Laura, et al.
Publicado: (2022)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Genomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5
por: Harrison, Odile B., et al.
Publicado: (2015)

A Bast-like valve in the pigeon?
por: Hofman, Rutger, et al.
Publicado: (2009)

Meningococcal infections among refugees and immigrants: silent threats of past, present and future
por: Dinleyici, Ener Cagri, et al.
Publicado: (2020)

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage
por: Lucidarme, Jay, et al.
Publicado: (2015)

Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
por: Christensen, Hannah, et al.
Publicado: (2014)

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
por: VÁZQUEZ, J. A., et al.
Publicado: (2016)

Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
por: Maiden, Martin C. J.
Publicado: (2013)

A world without bacterial meningitis: how genomic epidemiology can inform vaccination strategy
por: Rodrigues, Charlene M.C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qpcfn0nam4t2hsgl2t02tifi67